Riskpilot← Back to searchSign inGet full accessTriventa AB
ABActiveOrg 5592601529Berghauptmansgatan 58Medical specialists activities · NACE 8622Est. 20201 employees
Revenue 2025
SEK 402K
-7% vs 2024
EBITDA margin
2.9%
+103% vs 2024
Equity ratio
5.3%
Financial strength
Net profit 2025
SEK -45K
+90% vs 2024
| Revenue | SEK 402K | -7% |
| EBITDA | SEK 12K | +103% |
| Net profit | SEK -45K | +90% |
| Total assets | SEK 639K | +11% |
| Equity | SEK 34K | +19% |
| Employees | 1 | — |
Legal name
Triventa AB
Org number
5592601529
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
18 juni 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att äga och förvalta aktier och andelar i dotter- och intressebolag samt därmed förenlig verksamhet.
Address
Berghauptmansgatan 58
Email
camilla@dofs.nu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 20 | 0 | 43 | 433 | 402 |
| Staff expenses | — | — | −81 | −341 | −114 |
| EBITDA | −20 | −14 | −343 | −411 | 12 |
| Depreciation & amort. | −0 | — | −5 | −33 | −56 |
| EBIT | −20 | −14 | −349 | −444 | −44 |
| Net financials | — | 0 | 0 | −0 | −1 |
| Profit before tax | −20 | −14 | −349 | −444 | −45 |
| Tax | −0 | — | — | — | — |
| Net profit | −20 | −14 | −349 | −444 | −45 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 87 | 67 | 673 | 575 | 639 |
| Equity | 46 | 31 | 33 | 28 | 34 |
| Long-term debt | 0 | — | 2 | 3 | 0 |
| Short-term debt | 41 | 36 | 638 | 544 | 605 |
| Total debt | 41 | 36 | 640 | 546 | 605 |
EBITDA margin
2.9%
This company
15.8%
Market median
-82% vs market
20212025
Equity ratio
5.3%
This company
38.2%
Market median
-86% vs market
20212025
Return on equity
-131.9%
This company
18.4%
Market median
-817% vs market
20212025
Net profit margin
-11.1%
This company
8.1%
Market median
-237% vs market
20212025
Asset turnover
0.63×
This company
1.12×
Market median
-44% vs market
20212025
Debt / equity
17.90×
This company
0.62×
Market median
-2787% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MC Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Triventa AB 
Vitasalus ABBoard members of Triventa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Camilla Victoria Janericsdotter Dofs | Chief Executive Officer | 0 companies |
| Claes Göran Patrik Dofs | Board of Directors | 0 companies |
| Joakim Anders Christian Dofs | Chairman | 0 companies |